pentobarbital will decrease the level or outcome of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will lower the extent or influence of prednisone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
benzhydrocodone/acetaminophen and pentobarbital both boost sedation. Avoid or Use Alternate Drug. Limit use to sufferers for whom alternative therapy possibilities are insufficient
pentobarbital will decrease the extent or effect of erlotinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will lower the extent or effect of itraconazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unidentified.
Usage of sedative doses through labor does not impair uterine exercise, having said that, whole anesthetic dose can lessen the pressure and frequency of uterine contractions.
pentobarbital will minimize the level or result of atogepant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Proposed atogepant dosage with concomitant use of solid or reasonable CYP3A4 inducers is 30 mg or sixty mg qDay.
pentobarbital will minimize the extent or outcome of sulfamethoxazole by influencing hepatic enzyme CYP2C9/ten metabolism. Minimal/Importance Unfamiliar.
pentobarbital will lessen the extent or result of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will minimize the level or result of guanfacine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. more info Robust or reasonable CYP3A4 inducers significantly reduce guanfacine plasma concentrations and elimination 50 percent-everyday living.
pentobarbital will improve the amount or outcome of clopidogrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will reduce the level or impact of siponimod by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of siponimod that has a drug that triggers reasonable CYP2C9 as well as a average or potent CYP3A4 inducer isn't recommended.
pentobarbital will minimize the extent or impact of efavirenz by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unidentified.
pentobarbital improves toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers may well enhance the metabolism of ifosfamide to its Lively alkylating metabolites.